EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology

Xiaoqi Lin iD

Cytopathology · 2024

DOI: 10.1111/cyt.13384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, 2024. Verfasst von Xiaoqi Lin. Beteiligte Einrichtung: Department of Pathology, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Immunohistochemistry. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell papillary renal cell tumour (CCPRCT) was renamed from previous clear cell papillary renal cell carcinoma (CCPRCC) in the latest WHO Classification of Tumours. It is essential to differentiate RCC from CCPRCT in renal mass biopsies (RMB).

Design

RMB cases with subsequent resections were reviewed. The pathology reports and pertinent clinical information were recorded.

Results

Fifteen cases displaying either CCPRCT morphology (20% diffuse, 67% focal) or immunohistochemical patterns (cup‐like CA9: 20% diffuse, 47% focal; CK7: 33% diffuse, 40% focal) were identified. One case was positive for TFE3. TSC mutation was identified in one case. Both cases exhibited both CCPRCT morphology and immunohistochemical patterns for CA9 and CK7, with focal high‐grade nuclei. RMB diagnoses were as follows: 6 (40%) as CCRCC, 2 (13%) as CCPRCT, 2 (13%) as CCRCC versus CCPRCT, 2 (13%) as CCRCC versus PRCC, 1 (7%) as RCC with TSC mutation versus CCPRCT, 1 (7%) as TFE3‐rearranged RCC versus PRCC, and 1 (7%) as cyst with low‐grade atypia. 71% of patients underwent nephrectomy, 21% received systemic treatment for stage 4 RCCs, and 7% with ablation for small renal mass (1.6 cm) with low‐grade CCRCC.

Conclusions

Our study highlights that morphologic and immunochemical features of CCPRCT may be present in RCCs, including RCC‐TFE3 expression and TSC‐associated RCC, a critical pitfall to misdiagnose aggressive RCC as indolent CCPRCT and result in undertreatment. Careful examination of morphology and immunostains for CA9, CK7, and TFE3, as well as molecular tests, is crucial for distinguishing aggressive RCC from indolent CCPRCT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsImmunohistochemistryHumansFemaleMaleMiddle AgedAgedAdultBiomarkers, TumorKidneyBiopsyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCytodiagnosisDiagnosis, DifferentialMutation

Stichwörter der Autor:innen

clear cell papillary renal cell tumourcore needle biopsycytopathologyimmunohistochemistry, molecular testrenal cell carcinomatouch preparation

Substanzen

Biomarkers, TumorTFE3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription Factors

Autor:innen und Institutionen

  • Department of Pathology, Northwestern University, Chicago, Illinois, USA.

ORCID-Profile: Xiaoqi Lin

Zitieren

APA

Lin, X. (2024). Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology. Cytopathology. https://doi.org/10.1111/cyt.13384

Vancouver

Lin X. Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology. Cytopathology. 2024. doi:10.1111/cyt.13384

BibTeX
@article{Lin2024,
  author = {Lin, Xiaoqi},
  title = {Characteristic morphology and immunohistochemical patterns of clear cell papillary renal cell tumours may be observed in renal cell carcinomas, a critical pitfall in renal biopsy cytopathology},
  journal = {Cytopathology},
  year = {2024},
  doi = {10.1111/cyt.13384}
}
Kostenlos starten →